Status:
RECRUITING
Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples
Lead Sponsor:
Oslo University Hospital
Conditions:
Kidney Transplant Failure and Rejection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients will be randomize...
Detailed Description
Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients (i.e. first, kidn...
Eligibility Criteria
Inclusion
- Kidney only transplant
- Immunosuppressive therapy With at least one of; tacrolimus, cyclosporine, everolimus, sirolimus, mycophenolate
- Standard immunological risk; no DSA, no PRA, not ABO-incompatible transplant
- Age above 18 years
- Followed at Oslo University Hospital-Rikshospitalet transplant center
- Written informed consent
Exclusion
- Pregnant or breast feeding female recipients
- Ongoing acute rejection episodes at time of inclusion
Key Trial Info
Start Date :
April 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04369612
Start Date
April 28 2020
End Date
December 31 2024
Last Update
April 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo Univeristy Hospital - Rikshospitralet
Oslo, Norway, 0424